Munich Business Plan Competition 2024: Epicure has won the Munich Business Plan Competition 2024Epicure is developing a novel drug for cancer therapy based on epigenetic processes. These processes influence which genes are active in cells without altering the DNA itself. These mechanisms are of great importance in cancer research, as they contribute to better understanding, diagnosing, and treating cancer. Epicure's initial focus is on the treatment of leukemia. (Photo: Baystartup / Bert Willer)